» Articles » PMID: 37568181

The Influence of Protein Corona on Graphene Oxide: Implications for Biomedical Theranostics

Overview
Publisher Biomed Central
Specialty Biotechnology
Date 2023 Aug 11
PMID 37568181
Authors
Affiliations
Soon will be listed here.
Abstract

Graphene-based nanomaterials have attracted significant attention in the field of nanomedicine due to their unique atomic arrangement which allows for manifold applications. However, their inherent high hydrophobicity poses challenges in biological systems, thereby limiting their usage in biomedical areas. To address this limitation, one approach involves introducing oxygen functional groups on graphene surfaces, resulting in the formation of graphene oxide (GO). This modification enables improved dispersion, enhanced stability, reduced toxicity, and tunable surface properties. In this review, we aim to explore the interactions between GO and the biological fluids in the context of theranostics, shedding light on the formation of the "protein corona" (PC) i.e., the protein-enriched layer that formed around nanosystems when exposed to blood. The presence of the PC alters the surface properties and biological identity of GO, thus influencing its behavior and performance in various applications. By investigating this phenomenon, we gain insights into the bio-nano interactions that occur and their biological implications for different intents such as nucleic acid and drug delivery, active cell targeting, and modulation of cell signalling pathways. Additionally, we discuss diagnostic applications utilizing biocoronated GO and personalized PC analysis, with a particular focus on the detection of cancer biomarkers. By exploring these cutting-edge advancements, this comprehensive review provides valuable insights into the rapidly evolving field of GO-based nanomedicine for theranostic applications.

Citing Articles

Personalized nanovaccines for treating solid cancer metastases.

Feng T, Hu J, Wen J, Qian Z, Che G, Zhou Q J Hematol Oncol. 2024; 17(1):115.

PMID: 39609851 PMC: 11603676. DOI: 10.1186/s13045-024-01628-4.


Graphene Oxide Nanosheets Toxicity in Mice Is Dependent on Protein Corona Composition and Host Immunity.

Li Y, Mei K, Liam-Or R, Wang J, Faruqu F, Zhu S ACS Nano. 2024; 18(33):22572-22585.

PMID: 39110092 PMC: 11342366. DOI: 10.1021/acsnano.4c08561.


Multifaceted Characterization for the Hepatic Clearance of Graphene Oxide and Size-Related Hepatic Toxicity.

Su Z, Chen W, Liang S, Fang H, Zhang M, Wang M Molecules. 2024; 29(6).

PMID: 38542971 PMC: 10974896. DOI: 10.3390/molecules29061335.


3D-printed PCL framework assembling ECM-inspired multi-layer mineralized GO-Col-HAp microscaffold for in situ mandibular bone regeneration.

Yang Y, He H, Miao F, Yu M, Wu X, Liu Y J Transl Med. 2024; 22(1):224.

PMID: 38429799 PMC: 10908055. DOI: 10.1186/s12967-024-05020-1.

References
1.
Yao J, Wang H, Chen M, Yang M . Recent advances in graphene-based nanomaterials: properties, toxicity and applications in chemistry, biology and medicine. Mikrochim Acta. 2019; 186(6):395. DOI: 10.1007/s00604-019-3458-x. View

2.
Digiacomo L, Quagliarini E, Marmiroli B, Sartori B, Perini G, Papi M . Magnetic Levitation Patterns of Microfluidic-Generated Nanoparticle-Protein Complexes. Nanomaterials (Basel). 2022; 12(14). PMC: 9324036. DOI: 10.3390/nano12142376. View

3.
Jin C, Wang K, Oppong-Gyebi A, Hu J . Application of Nanotechnology in Cancer Diagnosis and Therapy - A Mini-Review. Int J Med Sci. 2020; 17(18):2964-2973. PMC: 7646098. DOI: 10.7150/ijms.49801. View

4.
Cheng Z, Li M, Dey R, Chen Y . Nanomaterials for cancer therapy: current progress and perspectives. J Hematol Oncol. 2021; 14(1):85. PMC: 8165984. DOI: 10.1186/s13045-021-01096-0. View

5.
Pozzi D, Marchini C, Cardarelli F, Rossetta A, Colapicchioni V, Amici A . Mechanistic understanding of gene delivery mediated by highly efficient multicomponent envelope-type nanoparticle systems. Mol Pharm. 2013; 10(12):4654-65. DOI: 10.1021/mp400470p. View